HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roger Strong Selected Research

caffeinol

2/2010Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.
1/2005Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
5/2003Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roger Strong Research Topics

Disease

7Cerebral Hemorrhage
03/2012 - 06/2006
5Hematoma
03/2012 - 04/2002
5Stroke (Strokes)
01/2012 - 05/2003
5Ischemia
02/2010 - 05/2003
4Infarction (Infarctions)
01/2012 - 05/2003
2Hemorrhage
03/2012 - 05/2003
2Ischemic Stroke
02/2010 - 05/2003
2Brain Ischemia (Cerebral Ischemia)
05/2009 - 06/2006
2Inflammation (Inflammations)
05/2007 - 06/2006
1Edema (Dropsy)
09/2011
1Brain Edema (Cerebral Edema)
01/2011
1Hypoxia (Hypoxemia)
10/2010
1Acute-Phase Reaction
12/2009
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2009
1Brain Diseases (Brain Disorder)
05/2009
1Neurologic Manifestations (Neurological Manifestations)
12/2007
1Brain Injuries (Brain Injury)
04/2007
1Cardiovascular Diseases (Cardiovascular Disease)
06/2006
1Hypothermia
05/2003

Drug/Important Bio-Agent (IBA)

4Transcription Factors (Transcription Factor)IBA
03/2012 - 05/2007
4PPAR gammaIBA
05/2009 - 06/2006
3caffeinolIBA
02/2010 - 05/2003
2HaptoglobinsIBA
01/2011 - 12/2009
2CytokinesIBA
10/2010 - 01/2010
2Ethanol (Ethyl Alcohol)IBA
02/2010 - 05/2003
2Caffeine (No Doz)FDA LinkGeneric
02/2010 - 05/2003
2Proteins (Proteins, Gene)FDA Link
12/2009 - 06/2006
2CatalaseIBA
05/2009 - 06/2006
2Messenger RNA (mRNA)IBA
06/2006 - 06/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2006 - 06/2006
1PS519IBA
03/2012
1Proteasome InhibitorsIBA
03/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2012
1Pharmaceutical PreparationsIBA
09/2011
1Dihydrotachysterol (AT 10)IBA
06/2011
1Hemoglobins (Hemoglobin)IBA
01/2011
1Carrier Proteins (Binding Protein)IBA
01/2011
1Oxygen (Dioxygen)IBA
10/2010
1Glucose (Dextrose)FDA LinkGeneric
10/2010
1EnzymesIBA
10/2010
1Caspase 3 (Caspase-3)IBA
10/2010
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2010
1Insulin (Novolin)FDA Link
10/2010
1Interleukin-10 (Interleukin 10)IBA
10/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2010
1N-Methylaspartate (NMDA)IBA
02/2010
1Glutathione Transferase (Glutathione S-Transferase)IBA
05/2009
1Superoxide Dismutase-1IBA
05/2009
1Liver X ReceptorsIBA
05/2009
1sulforaphaneIBA
12/2007
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2007
1Nitric Oxide Synthase (NO Synthase)IBA
05/2007
1NF-kappa B (NF-kB)IBA
05/2007
1Rosiglitazone (Avandia)FDA Link
04/2007
1Free RadicalsIBA
04/2007
14-O-carboxymethylascochlorinIBA
06/2006
1RNA (Ribonucleic Acid)IBA
06/2006
115-deoxyprostaglandin J2IBA
06/2006
1Insulin-Like PeptidesIBA
01/2005
1Therapeutic UsesIBA
05/2003
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2003
1Cytochromes c (Cytochrome c)IBA
04/2002

Therapy/Procedure

1Investigational Therapies (Experimental Therapy)
01/2012
1Intraventricular Injections
06/2006
1Intravenous Administration
05/2003